The UK Competition Authority clears an acquisition on the adherence packaging market (Omnicell / SurgiChem)

Competition Authority, UK

Previous article The UK Competition and Markets Authority refuses to apply the failing firm defence to clear a merger in phase II (Alliance / IBA) Next article The UK’s Business secretary proposes new safeguards to counteract the threat of foreign takeovers to the national interest (Pfizer / AstraZeneca)

8 Aug 2014

The UK Competition Authority clears an acquisition on the adherence packaging market (Omnicell / SurgiChem)

KEYWORDS

Reference

UK Competition Authority, Omnicell / SurgiChem, Report on the anticipated acquisition, 8 August 2014

The Competition and Markets Authority (CMA) has cleared Omnicell/MTS’s proposed acquisition of SurgiChem.* This confirms the CMA’s provisional decision which was published last month and has been made by a group of independent CMA panel members. Omnicell, Inc./MTS Medication Technologies,

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

UK Competition Authority
UK Competition & Markets Authority - CMA (London)

United Kingdom 363 contributions 90671 visits

Quotation

UK Competition Authority, The UK Competition Authority clears an acquisition on the adherence packaging market (Omnicell / SurgiChem), 8 August 2014, e-Competitions Pharma & Mergers, Art. N° 68559

Visites 265